BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28212996)

  • 1. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
    Schirosi L; Nannini N; Nicoli D; Cavazza A; Valli R; Buti S; Garagnani L; Sartori G; Calabrese F; Marchetti A; Buttitta F; Felicioni L; Migaldi M; Rea F; Di Chiara F; Mengoli MC; Rossi G
    Ann Oncol; 2012 Sep; 23(9):2409-2414. PubMed ID: 22357254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.
    Okuma Y; Hosomi Y; Watanabe K; Yamada Y; Horio H; Maeda Y; Okamura T; Hishima T
    BMC Cancer; 2014 May; 14():349. PubMed ID: 24885581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
    Yamada Y
    Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
    Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
    Front Oncol; 2021; 11():647512. PubMed ID: 34568003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of thymic epithelial tumors in a real-world dataset.
    Kurokawa K; Shukuya T; Greenstein RA; Kaplan BG; Wakelee H; Ross JS; Miura K; Furuta K; Kato S; Suh J; Sivakumar S; Sokol ES; Carbone DP; Takahashi K
    ESMO Open; 2023 Oct; 8(5):101627. PubMed ID: 37703595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Landscape of Thymic Epithelial Tumors: A Comprehensive Review.
    Elm L; Levidou G
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography radiomic feature analysis of thymic epithelial tumors: Differentiation of thymic epithelial tumors from thymic cysts and prediction of histological subtypes.
    Zhao W; Ozawa Y; Hara M; Okuda K; Hiwatashi A
    Jpn J Radiol; 2024 Apr; 42(4):367-373. PubMed ID: 38010596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the effectiveness of chemotherapy for thymic epithelial tumors using the CD-DST method.
    Yu L; Zhang BX; Du X; Yu Z; Yang XG; Jiang YX
    Thorac Cancer; 2020 May; 11(5):1160-1169. PubMed ID: 32196982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas.
    Mimae T; Tsuta K; Kondo T; Nitta H; Grogan TM; Okada M; Asamura H; Tsuda H
    Ann Oncol; 2012 Dec; 23(12):3129-3137. PubMed ID: 22700994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.
    Tateo V; Manuzzi L; De Giglio A; Parisi C; Lamberti G; Campana D; Pantaleo MA
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule multitarget antiangiogenic inhibitor treatments for advanced thymic epithelial tumors: A retrospective study.
    Shen W; Jin Y; Yu Y; Chen N; Fan Y
    Thorac Cancer; 2024 Jan; 15(2):122-130. PubMed ID: 38011005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.
    Fang W; Girard N; Cilento V; Goren E; Dibaba D; Ruffini E; Ahmad U; Appel S; Bille A; Boubia S; Brambilla C; Cangir AK; Detterbeck F; Falkson C; Filosso PL; Giaccone G; Guerrera F; Huang J; Infante M; Kim DK; Lucchi M; Marino M; Marom EM; Nicholson AG; Okumura M; Rami-Porta R; Rimner A; Simone CB; Asamura H;
    J Thorac Oncol; 2024 Jan; 19(1):52-70. PubMed ID: 37774950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic epithelial tumor treatment in Japan: analysis of hospital cancer registry and insurance claims data, 2012-2014.
    Kanemura H; Tamura T; Nishimura N; Kobayashi D; Higashi T
    Jpn J Clin Oncol; 2020 Mar; 50(3):310-317. PubMed ID: 31829410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.
    Khoury T; Chandrasekhar R; Wilding G; Tan D; Cheney RT
    Int J Exp Pathol; 2011 Apr; 92(2):87-96. PubMed ID: 21044186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
    Ardeshir-Larijani F; Schneider BP; Althouse SK; Radovich M; Masood A; Perna F; Salman H; Loehrer PJ
    JCO Precis Oncol; 2023 Feb; 7():e2200465. PubMed ID: 36787505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-energy CT perfusion imaging for differentiating WHO subtypes of thymic epithelial tumors.
    Yu C; Li T; Zhang R; Yang X; Yang Z; Xin L; Zhao Z
    Sci Rep; 2020 Mar; 10(1):5511. PubMed ID: 32218504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.
    Perrino M; Voulaz E; Balin S; Cazzato G; Fontana E; Franzese S; Defendi M; De Vincenzo F; Cordua N; Tamma R; Borea F; Aliprandi M; Airoldi M; Cecchi LG; Fazio R; Alloisio M; Marulli G; Santoro A; Di Tommaso L; Ingravallo G; Russo L; Da Rin G; Villa A; Della Bella S; Zucali PA; Mavilio D
    Front Immunol; 2024; 15():1288045. PubMed ID: 38629065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.
    Padda SK; Yao X; Antonicelli A; Riess JW; Shang Y; Shrager JB; Korst R; Detterbeck F; Huang J; Burt BM; Wakelee HA; Badve SS
    J Thorac Oncol; 2018 Mar; 13(3):436-446. PubMed ID: 29191778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
    Shimada M; Taniguchi H; Yamaguchi H; Gyotoku H; Sasaki D; Kaku N; Senju C; Senju H; Imamura E; Takemoto S; Yamamoto K; Sakamoto N; Obase Y; Tsuchiya T; Fukuda M; Soda H; Ashizawa K; Fukuoka J; Nagayasu T; Yanagihara K; Mukae H
    Transl Lung Cancer Res; 2023 Apr; 12(4):707-718. PubMed ID: 37197618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.